Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
Clin Exp Immunol. 2013 Sep;173(3):536-43. doi: 10.1111/cei.12127.
Antibodies recognizing denatured human leucocyte antigen (HLA) can co-react with epitopes on intact HLA or recognize cryptic epitopes which are normally unaccessible to HLA antibodies. Their specificity cannot be distinguished by single antigen beads (SAB) alone, as they carry a mixture of intact and denatured HLA. In this study, we selected pretransplant sera containing donor-specific HLA class I antibodies (DSA) according to regular SAB analysis from 156 kidney transplant recipients. These sera were analysed using a SAB preparation (iBeads) which is largely devoid of denatured HLA class I, and SAB coated with denatured HLA class I antigens. A total of 241 class I DSA were found by regular SAB analysis, of which 152 (63%) were also found by iBeads, whereas 28 (11%) were caused by reactivity with denatured DNA. Patients with DSA defined either by regular SAB or iBeads showed a significantly lower graft survival rate (P = 0·007) compared to those without HLA class I DSA, whereas reactivity to exclusively denatured HLA was not associated with decreased graft survival. In addition, DSA defined by reactivity to class I SAB or class I iBeads occurred more frequently in female patients and in patients with historic HLA sensitization, whereas reactivity to denatured HLA class I was not associated with any of these parameters. Our data suggest that pretransplant donor-specific antibodies against denatured HLA are clinically irrelevant in patients already sensitized against intact HLA.
识别变性人白细胞抗原 (HLA) 的抗体可以与完整 HLA 上的表位发生交叉反应,或识别通常无法被 HLA 抗体识别的隐蔽表位。由于它们携带完整和变性 HLA 的混合物,因此不能仅通过单一抗原珠 (SAB) 来区分其特异性。在这项研究中,我们根据 156 名肾移植受者的常规 SAB 分析,选择了含有供体特异性 HLA Ⅰ类抗体 (DSA) 的移植前血清。这些血清使用一种基本上不含变性 HLA Ⅰ类的 SAB 制剂 (iBeads) 和包被变性 HLA Ⅰ类抗原的 SAB 进行分析。通过常规 SAB 分析共发现 241 种 HLA Ⅰ类 DSA,其中 152 种 (63%) 通过 iBeads 也被发现,而 28 种 (11%) 是由与变性 DNA 的反应引起的。通过常规 SAB 或 iBeads 定义的 DSA 患者的移植物存活率明显低于无 HLA Ⅰ类 DSA 的患者 (P=0.007),而仅与变性 HLA 反应与移植物存活率降低无关。此外,通过对 I 类 SAB 或 I 类 iBeads 的反应定义的 DSA 更常发生在女性患者和有历史 HLA 致敏的患者中,而与变性 HLA Ⅰ类的反应与这些参数均无关。我们的数据表明,对于已经对完整 HLA 产生致敏的患者,移植前针对变性 HLA 的供体特异性抗体在临床上是无关紧要的。